302440 and SKBS Related Headlines
Go Back- SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions
- SK bioscience wins first UNICEF vaccine contract for influenza supplies
- SK bioscience Secures First UNICEF Procurement Contract Improving Vaccine Access
- SK bioscience Board Approves Financing Plan Supported by Korea Growth Fund
- SK bioscience signs vaccine technology transfer deal with Colombia's VECOL
- SK bioscience Signs Vaccine Technology Transfer Agreement with Colombia's VECOL to Advance Local Vaccine Manufacturing in Latin America
- SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support
- SK bioscience, IDT Biologika and Vaxxas Selected for Next-Generation Influenza Vaccine development Financed by the European Union
302440 and SKBS Related Press Releases
Go Back- SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions
- SK bioscience Secures First UNICEF Procurement Contract Improving Vaccine Access
- SK bioscience Board Approves Financing Plan Supported by Korea Growth Fund
- SK bioscience Signs Vaccine Technology Transfer Agreement with Colombia's VECOL to Advance Local Vaccine Manufacturing in Latin America
- SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support
- SK bioscience, IDT Biologika and Vaxxas Selected for Next-Generation Influenza Vaccine development Financed by the European Union
